Drug profile · INN
metaproterenol sulfate
ALUPENT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
metaproterenol sulfate (ALUPENT) is an FDA-listed pharmaceutical active ingredient. Associated with Aldeyra Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN metaproterenol sulfate
Brand ALUPENT
Route ORAL
Formulation AEROSOL, METERED
Originator Aldeyra Therapeutics
Frequently asked questions
What is metaproterenol sulfate?
metaproterenol sulfate (ALUPENT) is an FDA-listed pharmaceutical active ingredient. Associated with Aldeyra Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for metaproterenol sulfate?
ALUPENT is a marketed brand name for metaproterenol sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metaproterenol sulfate?
metaproterenol sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.